Opiant Pharmaceuticals, Inc.
OPNTDelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385508
Opiant Pharmaceuticals, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 37 institutions reported holding it in 13F filings for Q4 2022, worth $43.2M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Opiant Pharmaceuticals, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- −1 vs. Q4 2021
- Shares held
- 1.56M
- +140.6K (+9.9%) vs. Q4 2021
- Total value
- $33.3M
- −$14.3M (−30.0%) vs. Q4 2021
- New holders
- 9
- 12 more added
- Sold out
- 10
- 13 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OPNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 37 | $43.2M |
| Q3 2022 | 32 | $19.4M |
| Q2 2022 | 33 | $22.3M |
| Q1 2022 | 41 | $33.3M |
| Q4 2021 | 42 | $47.6M |
| Q3 2021 | 35 | $32.7M |
| Q2 2021 | 26 | $11.8M |
| Q1 2021 | 31 | $9.70M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Opiant Pharmaceuticals, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 205,226 | $4.40M | 0.00% | −19,071−8.5% | Reduced |
| Vanguard Group Inc | 187,158 | $4.01M | 0.00% | +8,699+4.9% | Added |
| Renaissance Technologies LLC | 178,015 | $3.81M | 0.00% | −5,800−3.2% | Reduced |
| Ovata Capital Management Ltd | 117,865 | $2.52M | 0.78% | +117,865 | New |
| Acadian Asset Management LLC | 116,478 | $2.49M | 0.01% | +44,562+62.0% | Added |
| Apis Capital Advisors, LLC | 112,000 | $2.40M | 2.90% | +2,000+1.8% | Added |
| Dimensional Fund Advisors LP | 106,682 | $2.29M | 0.00% | +40,031+60.1% | Added |
| Two Sigma Advisers, LP | 72,700 | $1.56M | 0.00% | −9,700−11.8% | Reduced |
| Geode Capital Management, LLC | 47,998 | $1.03M | 0.00% | −2,246−4.5% | Reduced |
| Two Sigma Investments, LP | 38,832 | $832.0K | 0.00% | −25,225−39.4% | Reduced |
| Northern Trust Corp | 37,078 | $794.0K | 0.00% | −772−2.0% | Reduced |
| BlackRock Inc. | 35,323 | $756.0K | 0.00% | +579+1.7% | Added |
| Parkman Healthcare Partners LLC | 32,557 | $697.0K | 0.20% | +1,266+4.0% | Added |
| Essex Investment Management Co LLC | 32,040 | $686.0K | 0.09% | +777+2.5% | Added |
| Perritt Capital Management Inc | 30,500 | $653.0K | 0.35% | −1,500−4.7% | Reduced |
| Morgan Stanley | 26,675 | $571.0K | 0.00% | −7,661−22.3% | Reduced |
| DLD Asset Management, LP | 20,000 | $428.0K | 0.03% | −10,000−33.3% | Reduced |
| HealthInvest Partners AB | 18,000 | $386.0K | 0.61% | +18,000 | New |
| D. E. Shaw & Co., Inc. | 16,989 | $364.0K | 0.00% | +16,989 | New |
| SG3 Management, LLC | 16,084 | $345.0K | 0.10% | +16,084 | New |
| Bailard, Inc. | 15,042 | $322.0K | 0.01% | −1,200−7.4% | Reduced |
| Marshall Wace, LLP | 13,584 | $291.0K | 0.00% | −9,993−42.4% | Reduced |
| Mariner, LLC | 13,550 | $290.0K | 0.00% | +13,550 | New |
| State Street Corp | 13,285 | $285.0K | 0.00% | +1,285+10.7% | Added |
| Trexquant Investment LP | 12,013 | $257.0K | 0.01% | +12,013 | New |
| Millennium Management LLC | 11,577 | $248.0K | 0.00% | +11,577 | New |
| Bridgeway Capital Management, LLC | 10,100 | $216.0K | 0.00% | −300−2.9% | Reduced |
| JPMorgan Chase & Co | 7,466 | $160.0K | 0.00% | +723+10.7% | Added |
| Advisor Group Holdings, Inc. | 5,425 | $116.0K | 0.00% | −2,700−33.2% | Reduced |
| Newbridge Financial Services Group, Inc. | 2,050 | $44.0K | 0.02% | +200+10.8% | Added |
| Royal Bank of Canada | 1,400 | $30.0K | 0.00% | +200+16.7% | Added |
| UBS Group AG | 1,022 | $22.0K | 0.00% | +717+235.1% | Added |
| Lindbrook Capital, LLC | 500 | $11.0K | 0.00% | 00.0% | Unchanged |
| Spire Wealth Management | 500 | $11.0K | 0.00% | 00.0% | Unchanged |
| American Research & Management Co. | 300 | $6.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 252 | $5.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 180 | $3.86K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 154 | $3.00K | 0.00% | +154 | New |
| National Bank of Canada | 100 | $2.00K | 0.00% | 00.0% | Unchanged |
| Sage Private Wealth Group, LLC | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 10 | $0 | 0.00% | +10 | New |
| EAM Investors, LLC | 0 | $0 | 0.00% | −44,771−100.0% | Sold out |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −7,803−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −6,417−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −5,180−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −3,200−100.0% | Sold out |
| Dorsey Wright & Associates | 0 | $0 | 0.00% | −2,138−100.0% | Sold out |
| TAP Consulting, LLC | 0 | $0 | 0.00% | −471−100.0% | Sold out |
| CoreCap Advisors, LLC | 0 | $0 | 0.00% | −266−100.0% | Sold out |
| Retirement Planning Co of New England, Inc. | 0 | $0 | 0.00% | −180−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −63−100.0% | Sold out |